1.Associations of physical activity, sedentary behavior, and sleep with risk of incident Parkinson's disease: A prospective cohort study of 401,697 participants.
Haishan JIAO ; Shuyi HUANG ; Wei CHENG ; Jianfeng FENG ; Jintai YU
Chinese Medical Journal 2025;138(7):819-828
BACKGROUND:
Physical activity, sedentary behavior (SB), and sleep duration are associated with brain health. Effects of those on developing Parkinson's disease (PD) are poorly investigated. This study aimed to examine the independent and joint associations of physical activity, SB, sleep with PD risk.
METHODS:
We analyzed data on 401,697 participants from the UK Biobank cohort, which was enrolled in 2006-2010. Physical activities were measured based on a questionnaire. Sleep and SB time were defined through self-reported total number of hours. Models fitted with restricted cubic spline were conducted to test for linear and non-linear shapes of each association. Cox proportional hazards regression models were used to estimate the association of three modifiable behaviors.
RESULTS:
Our analytic sample included 401,697 participants with 3030 identified cases of PD (mean age, 63 years; 62.9% male). PD risk was 18% lower in the high total physical activity group (95% CI, 0.75-0.90), 22% lower in the high leisure-time physical activity (LTPA) group (95% CI, 0.71-0.86) compared with the low level and 14% higher in the high sleep duration group (95% CI, 1.05-1.24) compared to moderate group. Total SB time was irrelevant with PD risk, while high TV viewing showed a 12% increase of PD risk compared to the low group (95% CI, 1.02-1.22). Low computer use (0 h/day) was associated with a 14% higher risk compared to 1 h/day use (95% CI, 1.04-1.26). Those associations were independent. A combination of 7 h/day sleep, moderate-to-high computer use, and moderate-to-vigorous intensity of LTPA showed lowest PD risk (HR, 0.70; 95% CI, 0.57-0.85).
CONCLUSIONS
Physical activity, SB, and sleep were associated with PD risks separately. Our findings emphasize the possibility for changing these three daily activities concurrently to lower the risk of PD. These findings may promote an active lifestyle for PD prevention.
Humans
;
Parkinson Disease/physiopathology*
;
Male
;
Sedentary Behavior
;
Female
;
Middle Aged
;
Exercise/physiology*
;
Prospective Studies
;
Sleep/physiology*
;
Aged
;
Surveys and Questionnaires
;
Proportional Hazards Models
;
Risk Factors
2.Development and reliability and validity test of the Ego Depletion Scale for Type 2 Diabetes Patients
Jiaxin YOU ; Rong XU ; Tian XIA ; Haishan HUANG ; Xiao LU ; Hong LIU ; Yan HUANG ; Qinghua LIU ; Xuna BIAN
Chinese Journal of Nursing 2025;60(19):2371-2377
Objective To develop the Ego Depletion Scale for Type 2 Diabetes Patients and evaluate its reliability and validity,and to provide a specific assessment tool for evaluating ego-depletion in self-management.Methods Guided by the self-control strength model,the initial scale was constructed through literature review,semi-structured interviews,2 rounds of expert consultation,and a pilot survey.A convenience sampling method was employed to recruit 460 patients with Type 2 Diabetes from the endocrinology department of a tertiary hospital in Wuhan,Hubei Province,between April and July 2024.They were randomly divided into 2 subsets for exploratory factor analysis and confirmatory factor analysis.Results A total of 451 valid questionnaires were collected.Exploratory factor analysis extracted 6 common factors,with a cumulative variance contribution of 73.231%.In confirmatory factor analysis,an item was deleted due to failing to meet the standardized loading value criterion.The revised Ego Depletion Scale for Type 2 Diabetes Patients comprised 6 dimensions and 22 items.The total Cronbach's α coefficient was 0.911;split-half reliability was 0.744;the content validity index was 0.860.Correlation coefficients between the total score and scores of each dimension of the scale and the total score of the Self-Regulatory Fatigue Scale ranged from 0.558 to 0.946(P<0.001).Conclusion The scale exhibits robust reliability and validity,serving as a scientifically instrument for assessing ego depletion in patients with Type 2 Diabetes.
3.Preliminary efficacy and safety analysis of modified SIOPEL-4 protocol for newly diagnosed pediatric hepatoblastoma with lung metastases
Jiaxin PENG ; Can HUANG ; An'an ZHANG ; Yali HAN ; Haishan RUAN ; Xiaoxia WANG ; Min XU ; Yuan XIN ; Liting YU ; Zhibao LYU ; Mingxuan FENG ; Shayi JIANG ; Yijin GAO
Chinese Journal of Pediatrics 2025;63(12):1343-1348
Objective:To assess the preliminary efficacy and safety of modified Société Internationale d′Oncologie Pédiatrique Epithelial Liver Tumor Study Group (SIOPEL)-4 protocol for pediatric hepatoblastoma (HB) with lung metastases.Methods:This prospective cohort study enrolled 27 newly diagnosed pediatric HB with lung metastases who received the modified SIOPEL-4 protocol at Shanghai Children′s Medical Center, Shanghai Jiao Tong University School of Medicine, and Shanghai Children′s Hospital between January 2020 to December 2023. Clinical characteristics, lung response rates to induction chemotherapy, treatment outcomes, prognostic factors and sever chemotherapy toxicities at different stages were analyzed. Survival analysis was performed by Kaplan-Meier method. Univariate prognostic analysis was conducted by Log-Rank test.Results:Of the 27 patients, there were 17 males and 10 females, with the age of 21 (15, 33) months. During the follow-up of 31 (12, 45) months for 17 continuous complete remission patients, 4 cases disease progression (2 cases death) and 6 cases relapse were observed. The 2-year event free survival (EFS) and overall survival (OS) rate was (58±11)% and (89±7)%, respectively. All the 27 patients had response to block 1-3 induction chemotherapy (cisplatin+doxorubicin), with 14 cases (52%) achieving complete response and 13 cases (48%) achieving partial response of lung metastatic lesions, the 2-year EFS rate was (81±12)% and (34±14)%, respectively ( χ 2=6.76, P=0.009), the 2-year OS rate was 100% and (79±13)%, respectively ( χ2=2.12, P=0.145). Patients with caudate lobe tumors or ≥10 pulmonary metastatic nodules had significantly lower EFS rates ( χ2=5.36, 7.84, P=0.021, 0.005, respectively). The incidence of grade 3/4 neutropenia after block 1-3 induction chemotherapy, CD (carboplatin+doxorubicin), and VI (vincristine+irinotecan) consolidation chemotherapy was 90% (73/81), 75% (58/77), and 31% (11/35), respectively. The incidence of grade 3/4 thrombocytopenia was 77% (62/81), 69% (53/77), and 14% (5/35), respectively. The incidence of grade 3/4 infections was 64% (52/81), 25% (19/77), and 20% (7/35), respectively. The differences between the groups were statistically significant ( χ2=43.51, 42.69, 33.00, all P<0.001). Two patients (10%) of the 20 evaluable patients for ototoxicity occurred grade 3 and higher hearing impairment, with 1 patient requiring a hearing aid. Conclusions:The modified SIOPEL-4 regimen shows good preliminary efficacy and safety in treating pediatric HB with lung metastases. The prognosis for patients with residual lesions in the lungs after induction chemotherapy needs to be improved. Attention should be given to the ototoxicity induced by high-dose cisplatin chemotherapy.
4.Development and reliability and validity test of the Ego Depletion Scale for Type 2 Diabetes Patients
Jiaxin YOU ; Rong XU ; Tian XIA ; Haishan HUANG ; Xiao LU ; Hong LIU ; Yan HUANG ; Qinghua LIU ; Xuna BIAN
Chinese Journal of Nursing 2025;60(19):2371-2377
Objective To develop the Ego Depletion Scale for Type 2 Diabetes Patients and evaluate its reliability and validity,and to provide a specific assessment tool for evaluating ego-depletion in self-management.Methods Guided by the self-control strength model,the initial scale was constructed through literature review,semi-structured interviews,2 rounds of expert consultation,and a pilot survey.A convenience sampling method was employed to recruit 460 patients with Type 2 Diabetes from the endocrinology department of a tertiary hospital in Wuhan,Hubei Province,between April and July 2024.They were randomly divided into 2 subsets for exploratory factor analysis and confirmatory factor analysis.Results A total of 451 valid questionnaires were collected.Exploratory factor analysis extracted 6 common factors,with a cumulative variance contribution of 73.231%.In confirmatory factor analysis,an item was deleted due to failing to meet the standardized loading value criterion.The revised Ego Depletion Scale for Type 2 Diabetes Patients comprised 6 dimensions and 22 items.The total Cronbach's α coefficient was 0.911;split-half reliability was 0.744;the content validity index was 0.860.Correlation coefficients between the total score and scores of each dimension of the scale and the total score of the Self-Regulatory Fatigue Scale ranged from 0.558 to 0.946(P<0.001).Conclusion The scale exhibits robust reliability and validity,serving as a scientifically instrument for assessing ego depletion in patients with Type 2 Diabetes.
5.Preliminary efficacy and safety analysis of modified SIOPEL-4 protocol for newly diagnosed pediatric hepatoblastoma with lung metastases
Jiaxin PENG ; Can HUANG ; An'an ZHANG ; Yali HAN ; Haishan RUAN ; Xiaoxia WANG ; Min XU ; Yuan XIN ; Liting YU ; Zhibao LYU ; Mingxuan FENG ; Shayi JIANG ; Yijin GAO
Chinese Journal of Pediatrics 2025;63(12):1343-1348
Objective:To assess the preliminary efficacy and safety of modified Société Internationale d′Oncologie Pédiatrique Epithelial Liver Tumor Study Group (SIOPEL)-4 protocol for pediatric hepatoblastoma (HB) with lung metastases.Methods:This prospective cohort study enrolled 27 newly diagnosed pediatric HB with lung metastases who received the modified SIOPEL-4 protocol at Shanghai Children′s Medical Center, Shanghai Jiao Tong University School of Medicine, and Shanghai Children′s Hospital between January 2020 to December 2023. Clinical characteristics, lung response rates to induction chemotherapy, treatment outcomes, prognostic factors and sever chemotherapy toxicities at different stages were analyzed. Survival analysis was performed by Kaplan-Meier method. Univariate prognostic analysis was conducted by Log-Rank test.Results:Of the 27 patients, there were 17 males and 10 females, with the age of 21 (15, 33) months. During the follow-up of 31 (12, 45) months for 17 continuous complete remission patients, 4 cases disease progression (2 cases death) and 6 cases relapse were observed. The 2-year event free survival (EFS) and overall survival (OS) rate was (58±11)% and (89±7)%, respectively. All the 27 patients had response to block 1-3 induction chemotherapy (cisplatin+doxorubicin), with 14 cases (52%) achieving complete response and 13 cases (48%) achieving partial response of lung metastatic lesions, the 2-year EFS rate was (81±12)% and (34±14)%, respectively ( χ 2=6.76, P=0.009), the 2-year OS rate was 100% and (79±13)%, respectively ( χ2=2.12, P=0.145). Patients with caudate lobe tumors or ≥10 pulmonary metastatic nodules had significantly lower EFS rates ( χ2=5.36, 7.84, P=0.021, 0.005, respectively). The incidence of grade 3/4 neutropenia after block 1-3 induction chemotherapy, CD (carboplatin+doxorubicin), and VI (vincristine+irinotecan) consolidation chemotherapy was 90% (73/81), 75% (58/77), and 31% (11/35), respectively. The incidence of grade 3/4 thrombocytopenia was 77% (62/81), 69% (53/77), and 14% (5/35), respectively. The incidence of grade 3/4 infections was 64% (52/81), 25% (19/77), and 20% (7/35), respectively. The differences between the groups were statistically significant ( χ2=43.51, 42.69, 33.00, all P<0.001). Two patients (10%) of the 20 evaluable patients for ototoxicity occurred grade 3 and higher hearing impairment, with 1 patient requiring a hearing aid. Conclusions:The modified SIOPEL-4 regimen shows good preliminary efficacy and safety in treating pediatric HB with lung metastases. The prognosis for patients with residual lesions in the lungs after induction chemotherapy needs to be improved. Attention should be given to the ototoxicity induced by high-dose cisplatin chemotherapy.
6.Research progress in preparation for future care for the elderly
Xinxue XI ; Ling LI ; Tieying ZENG ; Haishan HUANG ; Daiqi CHEN ; Zongfeng LIAO ; Jing MAO
Chinese Journal of Nursing 2024;59(21):2595-2601
The continued aging of the population has led to a surge in long-term care needs for the elderly.Proactive preparation for future care(PFC)for the elderly can effectively meet the care needs caused by aging,improve their physical and mental health,and promote the elderly to maximize their physiological,psychological and social functions,finally realizing healthy aging.This paper reviews the theoretical basis,concept connotation,measurement tools,influencing factors and intervention strategies of PFC for the elderly,and puts forward the prospects for future research,so as to provide references for potential mechanism and empirical research of PFC for Chinese seniors.
7.Influence of Recent Trial History on Interval Timing.
Taorong XIE ; Can HUANG ; Yijie ZHANG ; Jing LIU ; Haishan YAO
Neuroscience Bulletin 2023;39(4):559-575
Interval timing is involved in a variety of cognitive behaviors such as associative learning and decision-making. While it has been shown that time estimation is adaptive to the temporal context, it remains unclear how interval timing behavior is influenced by recent trial history. Here we found that, in mice trained to perform a licking-based interval timing task, a decrease of inter-reinforcement interval in the previous trial rapidly shifted the time of anticipatory licking earlier. Optogenetic inactivation of the anterior lateral motor cortex (ALM), but not the medial prefrontal cortex, for a short time before reward delivery caused a decrease in the peak time of anticipatory licking in the next trial. Electrophysiological recordings from the ALM showed that the response profiles preceded by short and long inter-reinforcement intervals exhibited task-engagement-dependent temporal scaling. Thus, interval timing is adaptive to recent experience of the temporal interval, and ALM activity during time estimation reflects recent experience of interval.
Animals
;
Mice
;
Reward
;
Time Factors
;
Cognition
;
Learning
;
Decision Making
;
Reinforcement, Psychology
8.Sulforaphane promotes brain organoids growth through promoting prefrontal development and neuronal differentiation
Ziwei TENG ; Yuhan SU ; Yue QIN ; Jindong CHEN ; Hui TANG ; Renrong WU ; Haishan WU ; Jing HUANG
Chinese Journal of Psychiatry 2022;55(3):204-213
Objective:By comparing the changes of brain differentiation and neuronal markers of brain organoids in different periods, this study aims to clarify the effect and possible mechanisms of sulforaphane on the development of brain organoids.Methods:Brain organoids differentiated from human induced pluripotent stem cells treated with sulforaphane were used in this study. The experimental group was treated with sulforaphane at different concentrations (1 μmol/L, 2 μmol/L, 5 μmol/L), and the control group was a blank group, with 20 organoids in each group. Immunofluorescence and hematoxylin-eosin staining (HE) were used to observe and compare the expression characteristics of brain markers and neuronal markers in different periods of the two groups after sulforaphane treatment. Ribonucleic Acid (RNA) sequencing analysis of differentially expressed genes, functional enrichment analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were conducted. Real-time Quantitative Reverse Transcriptase-mediated Polymerase Chain Reaction (qRT-PCR) was performed to further screen and verify the potential genes or possible targets that may be involved in sulforaphane in promoting the growth of brain organoids.Results:The sex determining region Y-box 2(SOX2), Forebrain protein forkhead box G1 (FOXG1), prefrontal cortex autism susceptibility candidate 2 (AUST2), and paired box 6 (PAX6) increased significantly in the brain organoids after 40 days of treatment with sulforaphane; the expression of neuron marker proteins like β-tubulin (TUJ1), neuronal nuclei (NeuN), recombinant microtubule associated protein 2 (MAP2) and T-brain-1 (TBR1) in the brain organoids also showed significant increase after 70 days of treatment with sulforaphane. RNA sequencing analysis revealed that compared with the control group, 105 up-regulated genes and 512 down-regulated genes were identified in the sulforaphane treatment group, which, in total, are 617 genes. qRT-PCR verified that the transcription levels of differentially expressed genes (SFTPC,AKR1C3,CXCR6,PRAP1,TMC8,GPR182,F2RL2,KCNJ10) are basically consistent with the sequencing results.Conclusion:AKR1C3,KCNJ10 and other genes may be involved in sulforaphane to promote the brain organoid prefrontal development and neuronal differentiation. This research helps to provide new experimental evidence that sulforaphane improves the cognition and symptoms of patients with mental illness and neurodegenerative diseases.
9.Sulforaphane promotes brain organoids growth through promoting prefrontal development and neuronal differentiation
Ziwei TENG ; Yuhan SU ; Yue QIN ; Jindong CHEN ; Hui TANG ; Renrong WU ; Haishan WU ; Jing HUANG
Chinese Journal of Psychiatry 2022;55(3):204-213
Objective:By comparing the changes of brain differentiation and neuronal markers of brain organoids in different periods, this study aims to clarify the effect and possible mechanisms of sulforaphane on the development of brain organoids.Methods:Brain organoids differentiated from human induced pluripotent stem cells treated with sulforaphane were used in this study. The experimental group was treated with sulforaphane at different concentrations (1 μmol/L, 2 μmol/L, 5 μmol/L), and the control group was a blank group, with 20 organoids in each group. Immunofluorescence and hematoxylin-eosin staining (HE) were used to observe and compare the expression characteristics of brain markers and neuronal markers in different periods of the two groups after sulforaphane treatment. Ribonucleic Acid (RNA) sequencing analysis of differentially expressed genes, functional enrichment analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were conducted. Real-time Quantitative Reverse Transcriptase-mediated Polymerase Chain Reaction (qRT-PCR) was performed to further screen and verify the potential genes or possible targets that may be involved in sulforaphane in promoting the growth of brain organoids.Results:The sex determining region Y-box 2(SOX2), Forebrain protein forkhead box G1 (FOXG1), prefrontal cortex autism susceptibility candidate 2 (AUST2), and paired box 6 (PAX6) increased significantly in the brain organoids after 40 days of treatment with sulforaphane; the expression of neuron marker proteins like β-tubulin (TUJ1), neuronal nuclei (NeuN), recombinant microtubule associated protein 2 (MAP2) and T-brain-1 (TBR1) in the brain organoids also showed significant increase after 70 days of treatment with sulforaphane. RNA sequencing analysis revealed that compared with the control group, 105 up-regulated genes and 512 down-regulated genes were identified in the sulforaphane treatment group, which, in total, are 617 genes. qRT-PCR verified that the transcription levels of differentially expressed genes (SFTPC,AKR1C3,CXCR6,PRAP1,TMC8,GPR182,F2RL2,KCNJ10) are basically consistent with the sequencing results.Conclusion:AKR1C3,KCNJ10 and other genes may be involved in sulforaphane to promote the brain organoid prefrontal development and neuronal differentiation. This research helps to provide new experimental evidence that sulforaphane improves the cognition and symptoms of patients with mental illness and neurodegenerative diseases.
10.Mental health of front-line staff in prevention of coronavirus disease 2019.
Ziwei TENG ; Jing HUANG ; Yan QIU ; Yuxi TAN ; Qiuping ZHONG ; Hui TANG ; Haishan WU ; Ying WU ; Jindong CHEN
Journal of Central South University(Medical Sciences) 2020;45(6):613-619
OBJECTIVES:
The coronavirus disease 2019 (COVID-19) pandemic is a global public health crisis, which elicits psychological problems in different population This study is to investigate the impact of COVID-19 on mental health in the front-line staff.
METHODS:
Patient Health Questionnare-9 (PHQ-9), Self-Rating Anxiety Scale (SAS), and Fatigue Self-assessment Scale (FSAS) were used to assess the depression, anxiety, and fatigue in front-line staff.
RESULTS:
The detection rates of depression, anxiety, and fatigue were 49.1%, 21.8%, and 76.0% among the front-line staff. The rates of depression, anxiety, and fatigue in community workers were higher than those in medical workers and other occupational staff (<0.01). The PHQ-9 of front-line staffs was negatively correlated with age, family income, family members' support, satisfaction of service objects, and sleep quality (all <0.01), while positively correlated with education level, fatigue, fear of pneumonia, and the duration of daily attention to the COVID-19 (all <0.01). SAS was negatively correlated with age, family income, family support, satisfaction of objects service, and sleep quality (all <0.01), while positively correlated with gender, fatigue, fear of pneumonia, and duration of daily attention to the COVID-19 (all <0.01).
CONCLUSIONS
The front-line workers should manage work and rest time reasonably to adjust their negative mood and fatigue. The government and the society should pay more attention to the psychological state of the front-line staff, particularly for the staff working in the community or villages and towns in preventing the COVID-19 pandemic. Thus, front-line staff can be obtained mental intervention or be taken a rest from the high-intensive work.
Anxiety
;
diagnosis
;
Betacoronavirus
;
Coronavirus Infections
;
prevention & control
;
psychology
;
Depression
;
diagnosis
;
Fatigue
;
diagnosis
;
Health Personnel
;
psychology
;
Humans
;
Mental Health
;
Pandemics
;
prevention & control
;
Pneumonia, Viral
;
prevention & control
;
psychology

Result Analysis
Print
Save
E-mail